Food: Launch High Value-added Products, Invest Intensely in Overseas Business

Meiji Holdings Co., Ltd. Financial Results for FYE March 2018and New Medium-term Business Plan

	TOP

	Financial Results for FYE March 2018 and New Medium-term Business Plan

	Agenda

	1. Overview of STEP UP 17

	2. The Meiji Group 2026 Vision

	3. The New Medium-term Business Plan Key Strategies Food: Expanding Yogurt, Chocolate, and Nutritional Products Food: Cultivate Future Growth Drivers Pharma: Maximize Product Value in Core Domains and Enhance Presence Pharma: Expand Sales of Generic Drugs and Accelerate Biosimilar Development to Drive Growth Food: Launch High Value-added Products, Invest Intensely in Overseas Business Pharma: Expand CMO/CDMO Business at Medreich Food: Continue Structural Reforms to Improve Productivity Food: Improve Profitability in Milk Business Pharma: Structural Reform and Platform Development to Grow Income from Overseas Agricultural Chemicals and Veterinary Drug Business KPIs - The New Medium-term Business Plan (1) KPIs - The New Medium-term Business Plan (2) Use of Cash Flows

	4. Outlook for the FYE March 2019

	Appendix: Financial data

	Appendix: Topics

	Back cover

Food: Launch High Value-added Products, Invest Intensely in Overseas Business

Prev. Page

Next Page

Download the PDF

Food segment
Increase investments

• Increase production capacity

• Possibility for strategic alliance and M&A

• Achieve net sales of JPY 90 billion in FYE March 2021

Focus on China

• Achieve JPY 23 billion in FYE March 2021 – double the current net sales

• Enhance product line in existing businesses

• Increasing importance of Ecommerce (EC)
Launch products exclusive to EC channels

• Planning to launch SAVAS brad products
Potential market for sports protein supplements, more health conscious consumers than in Japan